Analysis of serum levels of ALT and AST between the IN control group and groups INTR-API and INTR-NANO revealed a significant increase (P < 0.05) for animals treated during the patent period of infection, that is, 60 and 90 days p.i. (Figures 2A,B, 3A,B). The gene discussed is GPT; the disease is infection.